throbber
From: Johnson, Don
`
`
`
`Sent: 1/28/2015 2:15:19 PM
`
`
`
`To: TTAB EFiling
`
`
`
`CC:
`
`
`
`Subject: U.S. TRADEMARK APPLICATION NO. 85943027 - OMEGA SOUL - D 155/13 - EXAMINER BRIEF
`
`
`
`*************************************************
`
`Attachment Information:
`
`Count: 1
`
`Files: 85943027.doc
`
`
`
`
`
`

`
`UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO)
`
`
`
`U.S. APPLICATION SERIAL NO. 85943027
`
`
`
`MARK: OMEGA SOUL
`
`
`
`
`
`
`
`*85943027*
`
`CORRESPONDENT ADDRESS:
` MARIJAN STEPHAN HUCKE
`
`
`
`
`GENERAL TRADEMARK INFORMATION:
`
`http://www.uspto.gov/trademarks/index.jsp
`
`
`
`TTAB INFORMATION:
`
`http://www.uspto.gov/trademarks/process/appeal/index.js
`p
`
`
`
` HUCKE & HUCKE
`
`
`
` AN DER FUCHSKAUL 14
`
` PULHEIM, 50259 GERMANY
`
`
`
`
`
`APPLICANT: Nikos Alexakis AG
`
`
`
`
`
`
`
`CORRESPONDENT’S REFERENCE/DOCKET NO:
`
` D 155/13
`
`CORRESPONDENT E-MAIL ADDRESS:
`
` office@u-tm.com
`
`EXAMINING ATTORNEY’S APPEAL BRIEF
`
`
`
`
`
`

`
`Nikos Alexakis AG (hereinafter referred to as “Applicant”) has appealed the Office’s partial refusal to
`
`register the mark “OMEGA SOUL” (in standard characters) for use in Class 5 with “nutritional
`
`supplements.” Trademark Act Section 2(a), 15 U.S.C. §1052(a).
`
`
`
`
`
`I.
`
`
`
`FACTS
`
`On May 27, 2013, Applicant applied for registration on the Principal Register of the wording
`
`“OMEGA SOUL” (in standard characters) for use in Class 5 with “nutritional supplements.”
`
`On July 17, 2013, the Office initially partially refused registration of the mark pursuant to Trademark
`
`Act Section 2(a) because the mark consists of or includes deceptive matter in relation to nutritional
`
`supplements in Class 5, notified Applicant about prior pending application U.S. Serial No. 85421303,
`
`required the disclaimer of the word “OMEGA” with respect to the identified goods in Class 5, required
`
`an amendment to the identification of goods in Class 5 to avoid the Trademark Act Section 2(a)
`
`deceptiveness refusal, which amendment required Applicant to indicate that its nutritional supplements
`
`contain in significant part omega fatty acids, and required Applicant to submit a written statement
`
`verifying that its nutritional supplements contain in significant part omega fatty acids.
`
`On January 17, 2014, in its Response to Office action, Applicant noted that prior pending application
`
`U.S. Serial No. 85421303 had been abandoned, argued against the deceptiveness refusal as to its
`
`nutritional supplements, admitted its nutritional supplements do not contain omega fatty acids in
`
`significant part, did not amend its Class 5 identification of goods to include a representation that its
`
`nutritional supplements contain omega fatty acids in significant part, and disclaimed the exclusive right
`
`to use “OMEGA” apart from the mark as shown.
`
`

`
`On February 5, 2014, the Office acknowledged that prior pending application U.S. Serial No.
`
`85421303 had been abandoned, and maintained and made final the deceptiveness refusal as to
`
`Applicant’s nutritional supplements pursuant to Trademark Act Section 2(a).
`
`On August 5, 2014, in its Request for Reconsideration after Final Action, which was filed with its
`
`appeal to the Board, Applicant argued against the deceptiveness refusal as to its nutritional
`
`supplements.1
`
`On September 12, 2014, the examining attorney denied Applicant’s Request for Reconsideration.
`
`Applicant’s appeal resumed on September 29, 2014.
`
`
`
`
`
`
`
`II.
`
`ISSUE
`
`WHETHER THE APPLIED-FOR-MARK IS DECEPTIVE AS APPLIED TO THE CLASS 5 GOODS IN THE
`APPLICATION
`
`III.
`
`ARGUMENT
`
`
`As the Court of Appeals for the Federal Circuit explained in In re Budge Mfg. Co., 857 F.2d
`
`773, 775, 8 USPQ2d 1259, 1260 (Fed. Cir. 1988), the test for whether a mark consists of or
`
`comprises deceptive matter is:
`
` (1) Whether the applied-for mark consists of or contains a term that misdescribes the
`
`character, quality, function, composition, or use of the goods;
`
`
`1 The examining attorney notes that refusal on appeal pertains to class 5 only and were the applicant to be
`unsuccessful in its appeal, class 5 would be deleted from the application and class 28 would be approved for
`publication, which is contrary to the advisory in the Final action. 37 C.F.R. §2.65(a)(1),
`
`

`
` (2) If so, are prospective purchasers likely to believe that the misdescription actually
`
`describes the goods;
`
` (3) If so, is the misdescription likely to affect a significant portion of the relevant consumers’
`
`decision to purchase the goods.
`
`See also In re E5 LLC, 103 USPQ2d 1578 (TTAB 2012) (holding a mark consisting of the alpha symbol and
`
`letters “CU” deceptive for dietary supplements not containing copper, a common ingredient in dietary
`
`supplements, which evidence showed is referred to as CU).
`
`
`
`
`
`A. THE APPLIED-FOR-MARK CONSISTS OF OR CONTAINS A TERM THAT MISDESCRIBES THE
`COMPOSITION OF THE GOODS
`
`The goods at issue here are nutritional supplements. Applicant’s applied-for mark – OMEGA
`
`SOUL – includes the term “OMEGA,” which indicates the goods contain omega fatty acids, a group of
`
`fats that are thought by a substantial number of consumers to have health benefits. See Office action
`
`dated July 17, 2013, at 4-17, 44-55. Regarding the health benefits of these substances, the National
`
`Institutes of Health recognized that “Omega-3 fatty acids are a group of polyunsaturated fatty acids that
`
`are important for a number of functions in the body.” Id. at 48. The National Institutes of Health
`
`identified some of the functions for which Omega-3 fatty acids are important as “muscle activity, blood
`
`clotting, digestion, fertility, and cell division and growth.” Id. The National Institutes of Health further
`
`explained that one type of omega-3 fatty acid “is important for brain development and function” and
`
`that another is “an ‘essential’ fatty acid, meaning that people must obtain it from food or supplements
`
`because the human body cannot manufacture it.” Id.
`
`

`
`The evidence of record from www.webmd.com and www.en.wikipedia.org confirms the
`
`accuracy of these statements. WebMD stated:
`
`Nutritionists call omega-3 and omega-6 fatty acids ‘essential’ fats for good
`reason. The human body needs them for many functions, from building healthy
`cells to maintaining brain and nerve function. Our bodies cannot produce them.
`The only source is food. These polyunsaturated fats are important for another
`reason. There is growing evidence that they help lower the risk of heart disease.
`Some studies suggest these fats also protect against type 2 diabetes, Alzheimer’s
`disease, and age-related brain decline.
`
`
`
`See Final Office action dated February 5, 2014, at 2.
`
`Wikipedia identified other health benefits, stating that “Omega-3 fatty acids also have mild
`
`antihypertensive effects,” and that “[s]ome evidence suggests that people with certain circulatory
`
`problems, such as varicose veins, may benefit from the consumption of EPA and DHA [types of omega-3
`
`fatty acids], which may stimulate blood circulation, increase the breakdown of the fibrin, a compound
`
`involved in clot and scar formation, and, in addition, may reduce blood pressure.” See Office Action
`
`dated July 17, 2013, at 5.
`
`With respect to the extent of Americans’ use of omega fatty acids, the National Institutes of
`
`Health noted that, “[a]ccording to the 2007 National Health Interview Survey, which included a
`
`comprehensive survey on the use of complementary health approaches by Americans, fish oil/omega-
`
`3/DHA supplements are the nonvitamin/nonmineral, natural product most commonly taken by adults,
`
`and the second most commonly taken by children.” Id. at 50.
`
`1. OMEGA INDICATES THE IDENTIFIED GOODS CONTAIN OMEGA FATTY ACIDS
`
`The evidence of record shows that it is common in the nutritional supplements industry for
`
`products with OMEGA in their names to include omega fatty acids and that, as a result, consumers have
`
`

`
`come to expect the inclusion of such ingredient when the word OMEGA is used on labels of nutritional
`
`supplements. Specifically, this evidence shows that companies in the nutritional supplements industry
`
`use the word OMEGA in their advertisements of nutritional supplements containing omega fatty acids to
`
`market their products. This evidence contradicts Applicant’s argument that the word OMEGA without
`
`the accompanying numerals -3, -6, and/or -9 does not signify omega fatty acids, but that OMEGA only
`
`refers to omega fatty acids when used in conjunction with the numerals -3, -6, and/or -9.
`
`For example, the attachment at pages 29 and 31 to the Office action dated July 17, 2013,
`
`show a VitaminShoppe advertisement containing depictions of bottles of Nordic Naturals Ultimate
`
`Omega and Nordic Naturals Ultimate Omega + CoQ10, respectively, which products contain omega fatty
`
`acids but do not contain any of the numerals that applicant inaccurately contends are always on
`
`nutritional supplements containing omega fatty acids.
`
`Similarly, the attachment at page 44 to the Office action dated July 17, 2013, shows a Great
`
`HealthWorks advertisement containing a depiction of bottles of OMEGAXL, which product contains
`
`omega fatty acids but does not contain any of the cited numerals.
`
`Likewise, the evidence of record includes an AllStarHealth advertisement containing
`
`depictions of bottles of VEGA Vega – Antioxidant Omega Oil Blend and BARLEAN’S Omega Swirl Flax Oil
`
`Strawberry Banana, respectively, which contain omega fatty acids but do not contain any of the cited
`
`numerals. See Final Office action dated February 5, 2014, at 5-6.
`
`See also a GNC advertisement depicting a bottle of Nordic Naturals Ultimate Omega, id. at 7,
`
`a VitaminShoppe advertisement containing depictions of bottles of Nordic Naturals Ultimate Omega
`
`Minis, Nordic Naturals Ultimate Omega 1000 MG, and Nordic Naturals Ultimate Omega Xtra 1000 MG,
`
`id. at 8, and a GNC advertisement depicting a bottle of Nordic Naturals Ultimate Omega Liquid, id. at 9,
`
`all of the foregoing products contain omega fatty acids, but none of the portions of the marks used to
`
`

`
`denote the goods contain any of the numerals that applicant contends always accompany the word
`
`OMEGA to signify omega fatty acids.
`
`In the last cited VitaminShoppe advertisement, the depictions of omega fatty acid products
`
`using the word “OMEGA” without the numerals -3, -6, and/or -9 are intermixed with depictions of two
`
`omega fatty acid products that do use one or more of the numerals that Applicant relies upon, revealing
`
`the fact that, in the context of the nutritional supplements industry, the word “OMEGA” without the
`
`numerals -3, -6, and/or -9 is clearly a substitute for “OMEGA-3,” “OMEGA-6,” and/or “OMEGA-9.” Id. at
`
`8.
`
`2. “OMEGA SUPPLEMENTS” ARE A GENUS OF GOODS
`
`In addition, the evidence from www.luckyvitamin.com, www.vitaminshoppe.com, and
`
`www.gnc.com shows that a search of “omega supplements” will return a list of the venders’ omega fatty
`
`acid products with and without any specific reference to the type, be it -3, -6, or -9. This evidence shows
`
`that “omega supplements” are a genus of goods. Id. at 10-12, 24-25.
`
`Moreover, the evidence from http://www.swansonvitamins.com/q?kw=omega
`
`http://www.naturemade.com/search-results?query=omega, and
`
`http://www.amazon.com/s/ref=nb_sb_noss_2/178-7521211-9416111?url=search-alias%3Dhpc&field-
`
`keywords=%22omega%20supplements%22 shows that a search of “omega” alone on nutritional
`
`supplement industry websites will return a list of the venders’ omega fatty acid products with and
`
`without any specific reference to the type, be it -3, -6, or -9. This evidence also shows that “omega
`
`supplements” are a genus of goods and contradicts Applicant’s contention that consumers will not
`
`perceive OMEGA as a substance. See Denial of Request for Reconsideration dated September 12, 2014
`
`at 2-9.
`
`

`
`3. APPLICANT’S OWN EVIDENCE SHOWS OMEGA INDICATES THE IDENTIFIED
`GOODS CONTAIN OMEGA FATTY ACIDS
`
`Applicant’s own evidence states that OMEGA may refer to omega fatty acids. The
`
`attachments at pages 11 and 12 to Applicant’s Request for Reconsideration dated September 12, 2014,
`
`are webpages from Wiktionary, the free dictionary, which state: “Omega also may refer to: . . . Omega-3
`
`fatty acid, Omega-6 fatty acid, [and] Omega-9 fatty acid.” This evidence is consistent with Applicant’s
`
`disclaimer of the word “OMEGA” as to its use with nutritional supplements and with Applicant’s
`
`statement in its Response to Office Action that “applicant intends to introduce new products which do
`
`contain omega fatty acids in the future.” See Response to Office action dated January 17, 2014
`
`(Response to the Information Requirement).
`
`
`
`B. PROSPECTIVE PURCHASERS ARE LIKELY TO BELIEVE THAT THE MISDESCRIPTION
`ACTUALLY DESCRIBES THE GOODS
`
`
`
`Consumers would be likely to believe this misdescription in the mark, because the evidence
`
`of record from commonly used internet sources including Vitamin Shoppe, Great HealthWorks,
`
`AllStarHeealth, and GNC shows that it is common in applicant’s nutritional supplements industry for
`
`products with OMEGA in their names and without the numerals -3, -6, or -9 in their names to include
`
`omega fatty acids and that, as a result, consumers have come to expect such ingredient when the word
`
`OMEGA is used on labels of nutritional supplements. Specifically, this evidence shows other companies’
`
`advertisements of nutritional supplements containing omega fatty acids and their use of the word
`
`OMEGA without the numerals -3, -6, or -9 to market their products. See Office action dated July 17,
`
`2013, at 29, 31, 44; Final Office action dated February 5, 2014, at 5-9.
`
`
`
`

`
`C. THE MISDESCRIPTION IS LIKELY TO AFFECT A SIGNIFICANT PORTION OF THE RELEVANT
`CONSUMERS DECISION TO PURCHASE THE GOODS
`
`
`
`A misdescriptive ingredient would be material to the purchasing decision of a significant
`
`portion of the relevant consumers when the evidence demonstrates that the misdescription would
`
`make the product or service more appealing or desirable to prospective purchasers. See In re White
`
`Jasmine LLC, 106 USPQ2d at 1392 (citing In re Juleigh Jeans Sportswear Inc., 24 USPQ2d 1694, 1698-99
`
`(TTAB 1992)); TMEP §1203.02(d).
`
`In the present case, the health benefit evidence discussed above in Section III.A shows that
`
`nutritional supplements with omega fatty acids are more appealing or desirable because a large number
`
`of consumers believe that they have health benefit effects related to, for example, muscle activity,
`
`blood clotting, digestion, fertility, and cell division and growth. See Office action dated July 17, 2013, at
`
`4-17, 44-55; Final Office action dated February 5, 2014, at 2. The evidence from Wikipedia.com notes
`
`other potential benefits, stating that “omega-3 fatty acids have gained popularity for children with
`
`[attention deficit hyperactivity disorder and autism spectrum disorder]” and that research suggests that
`
`omega-3 fatty acids may have some anti-inflammatory benefits. Also the Great HealthWorks
`
`advertisement for OMEGAXL suggests health benefits in the areas of infant nutrition, cardiovascular
`
`disease, asthma, chronic pain relief, and cell aging. See Office action dated July 17, 2013, at 44-47. As a
`
`result of these potential health benefits from the use of omega fatty acids, fish oil/omega-3/DHA
`
`supplements were the nonvitamin/nonmineral natural product most commonly taken by American
`
`adults, and the second most commonly taken by American children in 2007. See Office action dated July
`
`17, 2013, at 50. Thus, the misdescription of Applicant’s products as “OMEGA” is highly likely to induce
`
`potential purchasers interested in obtaining these health benefits to buy Applicant’s products.
`
`D. APPLICANT’S AGRUMENTS ARE UNPERSUSIVE
`
`

`
`The evidence of record contradicts Applicant’s argument that, because Applicant’s mark
`
`does not include an accompanying numeral, consumers will perceive Applicant’s mark as a Greek letter,
`
`not as a message to consumers about omega-3 fatty acids.
`
`Applicant relies on the non-precedential decision of the Trademark Trial and Appeal Board
`
`in In re Omega Alpha Pharmaceuticals Inc., Application Serial Nos. 77486429 and 77486441 (March 26,
`
`2013), which found that “the examining attorney had failed to demonstrate that applicant’s marks –
`
`OMEGA ALPHA (in standard characters) and OMEGA ALPHA & design – are deceptive when used in
`
`connection with the identified goods (i.e., a variety of nutritional/herbal supplements). That finding,
`
`however, was based on a lack of evidence in the record of “the term OMEGA [being] used to describe an
`
`ingredient of a nutritional supplement.” The record in this case is very different, as the referenced
`
`evidence establishes.
`
`
`
`Applicant also argues that, if the definition of OMEGA is not a Greek letter, then it means “of or
`
`characterizing a chemical group or position at the end of a molecular chain.” Applicant’s Brief at 4.
`
`However, applicant’s argument overlooks the evidence that Applicant itself introduced, that being the
`
`Wiktionary, free dictionary evidence showing that, in addition to other meanings, “Omega also may
`
`refer to: . . . Omega-3 fatty acid, Omega-6 fatty acid, [and] Omega-9 fatty acid. See Applicant’s Request
`
`for Reconsideration dated September 12, 2014, at 11-12. The meaning of words clearly depends on
`
`context. The context in this case is nutritional supplements. In this context, OMEGA refers to Omega-3
`
`fatty acid, Omega-6 fatty acid, [and] Omega-9 fatty acid. Descriptiveness is determined in relation to the
`
`goods for which registration is sought. Therefore, the fact that a term may have different meaning in a
`
`different context is not controlling. See In re RiseSmart Inc., 104 USPQ2d 1931, 1933 (TTAB 2012,
`
`(finding that TALENT ASSURANCE does not present a double entendre such that “the merely descriptive
`
`significance of the term [TALENT] is lost in the mark as a whole”).
`
`

`
`
`
`Applicant argues that, under the OMEGA SOUL mark, it currently markets the product Garcinia
`
`Cambogia, which Applicant contends immediately communicates to the consumer what the product
`
`contains, i.e., Garcinia Cambogia. However, as the AllStarHealth advertisement containing depictions of
`
`bottles of VEGA Vega – Antioxidant Omega Oil Blend and BARLEAN’S Omega Swirl Flax Oil Strawberry
`
`Banana and the VitaminShoppe advertisement containing depictions of bottles of Nordic Naturals
`
`Ultimate Omega + CoQ10 show, nutritional supplement advertisements may include wording in addition
`
`to the word OMEGA to indicate that, in addition to omega fatty acids, the goods contain an additional
`
`ingredient, such as CoQ10. See Final Office action dated February 5, 2014, at 5-6; Office action dated
`
`July 17, 2013, at 5. Therefore, consumers purchasing OMEGA SOUL Garcinia Cambogia would be led to
`
`believe they were purchasing a nutritional supplement containing both ingredients when in fact they
`
`would be receiving merely a weight loss supplement that does not contain any of the health benefits of
`
`omega fatty acids, clearly and materially deceiving them into purchasing something that did not contain
`
`the beneficial ingredients which they sought.
`
`
`
`Applicant also argues that the examining attorney failed to consider Applicant’s mark as a
`
`whole. To the contrary, as with the above-referenced Ultimate Omega and OMEGAXL marks, the word
`
`OMEGA identifies the composition of the goods – omega fatty acids – and the other wording in the mark
`
`or other part of a compound mark (e.g., Ultimate or XL) is the source indicator. Thus, to the nutritional
`
`supplements consumer, OMEGA identifies the composition of the goods and SOUL serves as the source
`
`indicator. “It is well-established that a mark may be found deceptive on the basis of a single deceptive
`
`term that is embedded in a larger mark,” and a disclaimer of the deceptive matter cannot obviate a
`
`refusal under Trademark Act § 2(a) on the ground that the mark consists of or comprises deceptive
`
`matter. In re White Jasmine, 106 USPQ2d at 1391-92 n.22 (citing Am. Speech-Language-Hearing Ass’n v.
`
`Nat’l Hearing Aid Society, 224 U.S.P.Q. 798, 808 (TTAB 1984) and In re Charles S. Loeb Pipes. Inc., 190
`
`U.S.P.Q. 238, 241 (TTAB)).
`
`

`
`
`
`In support of its application for registration, Applicant also points to several third-party
`
`registrations that include the term OMEGA and that are for use with dietary and nutritional
`
`supplements. However, prior decisions and actions of other trademark examining attorneys in
`
`registering other marks have little evidentiary value and are not binding upon the USPTO or the
`
`Trademark Trial and Appeal Board. TMEP §1207.01(d)(vi); see In re Midwest Gaming & Entm’t LLC, 106
`
`USPQ2d 1163, 1165 n.3 (TTAB 2013) (citing In re Nett Designs, Inc., 236 F.3d 1339, 1342, 57 USPQ2d
`
`1564, 1566 (Fed. Cir. 2001)). Each case is decided on its own facts, and each mark stands on its own
`
`merits. See AMF Inc. v. Am. Leisure Prods., Inc., 474 F.2d 1403, 1406, 177 USPQ 268, 269 (C.C.P.A. 1973).
`
`
`
`
`
`IV.
`
`CONCLUSION
`
`Applicant applied for registration on the Principal Register of the wording “OMEGA SOUL”
`
`(in standard characters) for use in Class 5 with nutritional supplements. Applicant admitted in its
`
`Response to Office action that its Class 5 nutritional supplements do not contain omega fatty acids in
`
`significant part.
`
`Applicant’s applied-for mark is deceptive because it contains a term -- OMEGA -- that misdescribes
`
`the composition of the goods and is likely to lead prospective consumers to believe that the goods
`
`contain an ingredient that it does not contain and affect a significant portion of the relevant consumers’
`
`decision to purchase the goods.
`
`For the foregoing reasons, the refusal to register pursuant to Trademark Act Section 2(a), 15 U.S.C.
`
`§1052(a) should be affirmed.
`
`
`
`

`
`Respectfully submitted,
`
`/Donald Johnson/
`
`Examining Attorney
`
`Law Office 104
`
`(571) 272-7831
`
`don.johnson@uspto.gov
`
`
`
`
`
`Chris Doninger
`
`Managing Attorney
`
`Law Office 104

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket